Penserra Capital Management LLC Kaleido Biosciences, Inc. Transaction History

Penserra Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$2.39 - $6.02 $2,318 - $5,839	-970 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$5.82 - $8.72 $174 - $261	30 Added 3.19%	970 $7,000
Q1 2021 May 13, 2021	BUY	$7.2 - $16.82 $648 - $1,513	90 Added 10.59%	940 $7,000
Q4 2020 Feb 12, 2021	BUY	$5.77 - $11.33 $4,904 - $9,630	850 New	850 $7,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.